Healthcare
Veradigm Inc.(MDRX)
Live Price
Offline$4.80
-1.03% today
1Y Change
+6.67%
Window
Jun 25, 2025 โ Jun 16, 2026
- Market Cap
- $870.00M
- Revenue Growth
- +1.8%
- EPS Growth
- -165.0%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 25, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Veradigm Inc. (MDRX) is a Healthcare stock with a market cap of $870.00M and listed on OTC. The stock last traded around $4.80 and up 6.7% across the available one-year price window (Jun 25, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of +1.8%, EPS growth of -165.0%, a dividend yield of 0.0%. What stands out right now is revenue +1.8%, EPS -165.0%, free cash flow +206.1% with operating margin -4.6% and ROIC -0.7%. Valuation is more restrained than many high-expectation growth names at price/sales 1.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines MDRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+1.8% vs +7.6% peer median
Operating Margin
Below sector median
-4.6% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 8, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +1.8% and EPS is at -165.0%, with operating margin around -4.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -0.3% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 8, 2026 | โ | +4.3% | +12.1% | +14.3% |
2026 Feb 27, 2026 | +0.0% | -8.2% | -13.1% | -6.5% |
2025 Nov 7, 2025 | +0.0% | -1.0% | +0.0% | +3.1% |
Benchmark Edge
MDRX vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
MDRX
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
MDRX Max Drawdown
-20.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for MDRX and SPY.
Company Overview
Veradigm Inc.
Other OTC
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
- Leadership
- Donald D. Trigg
- IPO Date
- Jul 26, 1999
- Employees
- 2.5k
- Street Address
- 222 Merchandise Mart Plaza
- Mailing
- Chicago, IL, 60654
- Region
- Chicago, IL, US
- Reporting Currency
- USD
- Investor Line
- 800 334 8534
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 10.9
- Price/Sales
- 1.5
- Price/Book
- 0.6
Growth
- Revenue
- +1.8%
- EPS
- -165.0%
- Free Cash Flow
- +206.1%
Profitability
- Gross Margin
- 52.5%
- Operating Margin
- -4.6%
- Net Margin
- -14.7%
- ROE
- -7.1%
- ROIC
- -0.7%
Balance Sheet
- Debt/Equity
- 0.22
- Current Ratio
- 2.95
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.